ATA Annual Meeting | Conferences

Higher BMI May Induce More Aggressive Disease, Worse Clinical Outcomes in Differentiated Thyroid Carcinoma

October 21, 2022

Investigators found that higher body mass index is associated with more aggressive differentiated thyroid carcinoma tumors, as well as an increased risk for worse clinical outcomes, with patients with a BMI above 28.4 being at a higher risk.

Withholding RAI Therapy in Low-Risk Pediatric DTC Continues to Yield Comparable Remission Rates

October 20, 2022

Following American Thyroid Association guidelines, a retrospective study confirmed that remission rates were comparable in pediatric patients with low-risk differentiated thyroid carcinoma who did and did not receive radioactive iodine therapy.